DARC in-silico antibody design collaboration (University of Southampton)

UCB and the University of Southampton announced DARC, a three-year effort to build an end-to-end in-silico platform for therapeutic antibody design. UCB's head of UK research says the partnership strengthens UCB's position in AI-enabled antibody design.